高级检索
    钟雨玲, 王婧怡, 邬麟. 从TRIDENT-1研究看ROS1融合阳性局部晚期或转移性非小细胞肺癌一线治疗进展[J]. 循证医学, 2024, 24(4): 216-221. DOI: 10.12019/j.issn.1671-5144.202408004
    引用本文: 钟雨玲, 王婧怡, 邬麟. 从TRIDENT-1研究看ROS1融合阳性局部晚期或转移性非小细胞肺癌一线治疗进展[J]. 循证医学, 2024, 24(4): 216-221. DOI: 10.12019/j.issn.1671-5144.202408004
    shu
    ZHONG Yu-ling, WANG Jing-yi, WU Lin. Progress in First-Line Treatment of ROS1 Fusion-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer From TRIDENT-1 Study[J]. Journal of Evidence-Based Medicine, 2024, 24(4): 216-221. DOI: 10.12019/j.issn.1671-5144.202408004
    Citation: ZHONG Yu-ling, WANG Jing-yi, WU Lin. Progress in First-Line Treatment of ROS1 Fusion-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer From TRIDENT-1 Study[J]. Journal of Evidence-Based Medicine, 2024, 24(4): 216-221. DOI: 10.12019/j.issn.1671-5144.202408004
    shu

    从TRIDENT-1研究看ROS1融合阳性局部晚期或转移性非小细胞肺癌一线治疗进展

    Progress in First-Line Treatment of ROS1 Fusion-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer From TRIDENT-1 Study

      摘要
      • HTML全文
      • 参考文献(20)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回